HIV Researcher Forced to Remove Terms From Grant by Trump NIH

“Her story is not unique,” said Shalini Agarwal, special counsel at Project Democracy.

Federal health researchers face escalating political reviews that force them to scrub specific terminology from peer-reviewed projects, according to data and interviews reported by the Guardian.

Dr Jade Pagkas-Bather secured her first grant from the National Institutes of Health in June 2025. She designed a randomized control trial to test whether monthly $500 cash grants helped low-income, HIV-positive young people in Chicago maintain their medical treatments.

“Maybe taking care of your HIV isn’t your priority when you’re unhoused or hungry,” Pagkas-Bather said.

“We had something that said we would include people of all gender identities in the grant. Program officers asked us to remove the term 'gender identities.' We had a clause that said Black and Latinx people experience more poverty than other people. They asked us to remove that,” Dr Jade Pagkas-Bather said, noting NIH program officers later instructed her to remove references to gender identities, specific racial demographics experiencing poverty, and the basic income acronym.

By 2026, administrators demanded she strip out the unconditional cash transfer mechanism entirely and eliminate any mention of policy impacts. Grant renegotiations at the agency have surged under the Trump administration, introducing widespread uncertainty into biomedical funding.

Trump's NIH Told HIV Scientist to Delete Cash From Her Own Study — Blue Wave Democrats

A Grant Witness analysis found changes to active federal grants rose sharply during the past three years. In 2023, just 154 out of more than 40,000 grants up for renewal altered their titles, abstracts, or public health statements, representing 0.4% of all awards.

That figure climbed to 8.6% in 2025, with more than 3,401 alterations among roughly 39,000 continuing grants. In 2026, changes affected 3,006 grants, or 8.5% of the agency’s nearly 35,500 continuing awards.

HIV-related projects faced particularly high rates of intervention. In 2025, officials altered 305 out of 1,795 continuing HIV grants, hitting 17%. The rate rose to 20.8% in 2026, when 335 out of 1,609 continuing grants underwent forced text revisions.

“The censorship that’s happening now is, I think, pretty much unprecedented,” said Jeremy Berg, a former director of the National Institute of General Medical Sciences. “It’s very Orwellian in the sense that it’s purely double-speak.”

The review mechanism relies on a text analysis tool designed to flag projects deemed misaligned with administration priorities, such as the view that gender is binary and that health equity research is unscientific. Program officers tasked with shepharding grants must contact investigators to secure compliance.

“We are compelled,” said National Cancer Institute branch chief Sarah Kobrin. “We are not calling and saying, ‘Hey, could you change these words.’ Instead, program officers must ask: ‘Hey, you know, if you want, you could change these words and it might work out well for you.’”

An NIH spokesperson defended the process to the Guardian, stating that the agency renegotiated more than 5,000 new and continuation grants to ensure funding supports meritorious science and addresses urgent health needs. The spokesperson added that grant scopes were substantively altered to replace subjective concepts with well-defined, objective variables under human expert assessment.

Pagkas-Bather joined 13 other researchers as a named plaintiff in a First Amendment lawsuit filed by Project Democracy. The legal challenge alleges the administration’s renegotiation and cancellation practices constitute unlawful viewpoint-based discrimination.

Faced with the choice of losing her $1.3m funding or dropping cash assistance, Pagkas-Bather substituted food and transportation vouchers for direct cash payments. A federal court hearing in November will determine whether her lawsuit proceeds as a class action.

Photo of author

Omar El Sayed - World Editor

Omar El Sayed is Archyde’s World Editor, focused on international affairs, diplomacy, conflict, and cross-border political developments. He brings a global newsroom perspective to complex events and helps readers understand how regional stories connect to wider geopolitical shifts.

MP High Court Rejects 18 Lakh Accident Compensation Claim Due to Fraudulent Vehicle Planting